TickerFacts.

A business in context

NKTR research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-09-07 · 8010 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 4 · Ownership change

    Report date 2026-08-18 · 0001193125-26-359588

  2. 4 · Ownership change

    Report date 2026-08-18 · 0001193125-26-359586

  3. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001193125-26-349805

  4. 8-K · Current report

    Report date 2026-08-13 · 0001213900-26-089137 · Items 2.02,9.01

  5. 4 · Ownership change

    Report date 2026-07-24 · 0001193125-26-316458

  6. 4 · Ownership change

    Report date 2026-07-24 · 0001193125-26-316457

  7. 4 · Ownership change

    Report date 2026-06-30 · 0001193125-26-295112

  8. 4 · Ownership change

    Report date 2026-06-16 · 0001193125-26-276236

  9. 4 · Ownership change

    Report date 2026-06-15 · 0001193125-26-274534

  10. 8-K · Current report

    Report date 2026-06-05 · 0001213900-26-065845 · Items 5.07

  11. 4 · Ownership change

    Report date 2026-05-19 · 0001193125-26-235030

  12. 8-K · Current report

    Report date 2026-05-08 · 0001193125-26-214976 · Items 1.01,5.02,9.01

  13. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001193125-26-212596

  14. 8-K · Current report

    Report date 2026-05-07 · 0001213900-26-053369 · Items 2.02,9.01

  15. DEF 14A · Proxy statement

    Report date 2026-06-04 · 0001140361-26-016708

  16. 8-K · Current report

    Report date 2026-04-21 · 0001193125-26-171731 · Items 1.01,8.01,9.01

  17. 8-K · Current report

    Report date 2026-04-20 · 0001193125-26-164186 · Items 7.01

  18. 8-K · Current report

    Report date 2026-04-20 · 0001193125-26-162763 · Items 7.01,8.01,9.01

  19. 10-K · Annual report

    Report date 2025-12-31 · 0001193125-26-104547

  20. 8-K · Current report

    Report date 2026-03-12 · 0001213900-26-027026 · Items 2.02,9.01

  21. 8-K · Current report

    Report date 2026-02-11 · 0001193125-26-049378 · Items 1.01,8.01,9.01

  22. 8-K · Current report

    Report date 2026-02-10 · 0001193125-26-044751 · Items 7.01

  23. 8-K · Current report

    Report date 2026-02-10 · 0001193125-26-043755 · Items 7.01,8.01,9.01

  24. 8-K · Current report

    Report date 2026-01-27 · 0001213900-26-008210 · Items 7.01,9.01

  25. 8-K · Current report

    Report date 2025-12-16 · 0001193125-25-320009 · Items 7.01,8.01,9.01

  26. 8-K · Current report

    Report date 2025-11-21 · 0001213900-25-113606 · Items 5.02,9.01

  27. 8-K · Current report

    Report date 2025-11-08 · 0001213900-25-107821 · Items 7.01,8.01,9.01

  28. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001193125-25-270230

  29. 8-K · Current report

    Report date 2025-11-06 · 0001213900-25-107180 · Items 2.02,9.01

  30. 8-K · Current report

    Report date 2025-09-18 · 0001213900-25-088792 · Items 7.01,8.01,9.01

  31. 10-Q · Quarterly report

    Report date 2025-06-30 · 0000950170-25-105275

  32. 8-K · Current report

    Report date 2025-08-07 · 0001213900-25-073100 · Items 2.02,9.01

  33. 8-K · Current report

    Report date 2025-06-30 · 0001193125-25-154062 · Items 1.01,8.01,9.01

  34. 8-K · Current report

    Report date 2025-06-24 · 0001213900-25-059115 · Items 8.01

  35. 8-K · Current report

    Report date 2025-06-24 · 0001213900-25-056909 · Items 7.01,8.01,9.01

  36. 8-K · Current report

    Report date 2025-06-06 · 0001213900-25-052141 · Items 5.03,9.01

  37. 8-K · Current report

    Report date 2025-06-04 · 0001213900-25-051191 · Items 8.01

  38. 8-K · Current report

    Report date 2025-05-23 · 0001213900-25-047890 · Items 5.07

  39. 10-Q · Quarterly report

    Report date 2025-03-31 · 0000950170-25-067279

  40. 8-K · Current report

    Report date 2025-05-08 · 0001213900-25-041085 · Items 2.02,9.01

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-09-07 · 2026 Q2: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 7 transaction rows7SGrant / award: 0 transaction rows0AExercise / conversion: 0 transaction rows0MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

7 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-06-17
2026-06-18
ROBIN HOWARD WS · Sale
Disposed
Common Stock5500.060.81
2026-06-17
2026-06-18
ROBIN HOWARD WS · Sale
Disposed
Common Stock4500.061.65
2026-06-16
2026-06-18
ROBIN HOWARD WS · Sale
Disposed
Common Stock5303.059.97
2026-06-16
2026-06-18
ROBIN HOWARD WS · Sale
Disposed
Common Stock4697.060.71
2026-06-15
2026-06-17
Zalevsky JonathanS · Sale
Disposed
Common Stock5538.060.71
2026-05-19
2026-05-21
Zalevsky JonathanS · Sale
Disposed
Common Stock199.065.51
2026-05-19
2026-05-21
ROBIN HOWARD WS · Sale
Disposed
Common Stock444.065.51

Identity & relationships

Wikidata structured data · retrieved 2026-09-07 · 1611 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0000906709NEKTAR THERAPEUTICS

No parent relationship is available in this import; this is not proof of independence.

Legal Entity Identifier
5299005I24806IOIYE03
GLEIF legal name
NEKTAR THERAPEUTICS
Entity / LEI registration status
ACTIVE / LAPSED
Reference data updated
2021-07-14T05:31:46Z

direct-parent: no parent LEI supplied

ultimate-parent: no parent LEI supplied

GLEIF legal entity reference data · retrieved 2026-09-07 · 1177 checked identities; 0 unavailable records

Search names and former names

View Wikidata identity and references ↗

  • INHALE THERAPEUTIC SYSTEMS INC · former SEC name · 1998-10-15 to 2003-01-10
  • INHALE THERAPEUTIC SYSTEMS · former SEC name · 1996-07-11 to 1998-05-14
Explore headquarters map ↗

Revenue in constant purchasing power

USD revenue expressed in 2026-07 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$98.43M$104.77M
2023-12-31$90.12M$98.76M
2022-12-31$92.06M$105.02M
2021-12-31$101.91M$125.56M
2020-12-31$152.91M$197.29M
2019-12-31$114.62M$149.69M
2018-12-31$1.19B$1.59B
2017-12-31$307.71M$419.17M

Bureau of Labor Statistics · retrieved 2026-09-07 · 9 selected series; gaps remain missing

Explore the CPI history ↗